Alejandro Espadas de Arias, Simone Elizabeth Haworth, Luca Saverio Belli, Patrizia Burra, Giovambattista Pinzello, Marcello Vangeli, Ernesto Minola, Maria Guido, Patrizia Boccagni, Tullia Maria De Feo, Rosanna Torelli, Massimo Cardillo, Mario Scalamogna, Francesca Poli – 26 March 2009 – In 20% to 30% of infected individuals, hepatitis C virus (HCV) can cause cirrhosis and hepatocellular carcinoma, for which liver transplantation is the best treatment available.

James D. Perkins – 26 March 2009

Anne Marie Roque‐Afonso – 25 February 2009

Susagna Padrissa‐Altés, Rosa Franco‐Gou, Olivier Boillot, Anna Serafín, Antoni Rimola, Vicente Arroyo, Joan Rodés, Carmen Peralta, Joan Roselló‐Catafau – 25 February 2009 – This study examined whether angiotensin II (Ang II) blockers [Ang II type I receptor antagonist, Ang II type II receptor antagonist, and angiotensin converting enzyme (ACE) inhibitor] could reduce hepatic injury and improve regeneration in reduced‐size orthotopic liver transplantation (ROLT) and whether the beneficial effects of ischemic preconditioning (PC) in ROLT could be explained by changes in Ang II.

Edward Alabraba, Peter Nightingale, Bridget Gunson, Stefan Hubscher, Simon Olliff, Darius Mirza, James Neuberger – 25 February 2009 – Previously, we have found that the absence of the colon after liver transplantation (LT) protects the patient from recurrent primary sclerosing cholangitis (rPSC). As our previous observation has not been confirmed in other series, we have reviewed our cohort of patients grafted for primary sclerosing cholangitis (PSC) with greater numbers and longer follow‐up to reassess the rate, consequences, and risk factors for rPSC.

Johan Ungerstedt, Greg Nowak, Urban Ungerstedt, Bo‐Göran Ericzon – 25 February 2009 – Early detection of vascular complications following liver surgery is crucial. In the present study, intrahepatic microdialysis was used for continuous monitoring of porcine liver metabolism during occlusion of either the portal vein or the hepatic artery. Our aim was to assess whether microdialysis can be used to detect impaired vascular inflow by metabolic changes in the liver. Changes in metabolite concentrations in the hepatic interstitium were taken as markers for metabolic changes.

Jörg Schrader, Jonathan Fallowfield, John P. Iredale – 25 February 2009

Ying Luo, Chung Mau Lo, Cindy K. Cheung, George K. Lau, John Wong – 25 February 2009 – Cellular immunity plays an important role in the long‐term control of hepatitis B virus (HBV) infection. We studied the changes in HBV‐specific CD4 T cell immunity after orthotopic liver transplantation (OLT) for chronic hepatitis B under antiviral prophylaxis.

25 February 2009

M. Isabel Fiel, Thomas Schiano – 25 February 2009